Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase Ib, Open-Label, Dose- Escalation Trial of ACY-1215 in Combination With Gemcitabine and Cisplatin in Patients With Unresectable or Metastatic Cholangiocarcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02856568
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:33.646778+00:00
Published At
2017-05-30T00:00:00+00:00
Record Updated At
2017-05-30
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Non-Resectable Cholangiocarcinoma", "Recurrent Cholangiocarcinoma", "Stage III Extrahepatic Bile Duct Cancer", "Stage III Intrahepatic Cholangiocarcinoma", "Stage IIIA Hilar Cholangiocarcinoma", "Stage IIIB Hilar Cholangiocarcinoma", "Stage IVA Extrahepatic Bile Duct Cancer", "Stage IVA Hilar Cholangiocarcinoma", "Stage IVA Intrahepatic Cholangiocarcinoma", "Stage IVB Extrahepatic Bile Duct Cancer", "Stage IVB Hilar Cholangiocarcinoma", "Stage IVB Intrahepatic Cholangiocarcinoma", "Unresectable Extrahepatic Bile Duct Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-05-30"
protocolSection.identificationModule.nctId
"NCT02856568"
protocolSection.identificationModule.officialTitle
"A Phase Ib, Open-Label, Dose- Escalation Trial of ACY-1215 in Combination With Gemcitabine and Cisplatin in Patients With Unresectable or Metastatic Cholangiocarcinoma"
protocolSection.statusModule.overallStatus
"WITHDRAWN"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Non-Resectable Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Extrahepatic Bile Duct Cancer (protocolSection.conditionsModule.conditions)
  • Stage III Intrahepatic Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage IIIA Hilar Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage IIIB Hilar Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVA Extrahepatic Bile Duct Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVA Hilar Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVA Intrahepatic Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVB Extrahepatic Bile Duct Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVB Hilar Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVB Intrahepatic Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Unresectable Extrahepatic Bile Duct Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.